Idenix Pharmaceuticals (IDIX)
Add to Watchlists Create an Alert
4.18
+0.03 +0.72%
NASDAQ
May 23, 4:59PM
BATS Real time
Currency in USD
Idenix Pharmaceuticals Free Cash Flow:
-25.28M for March 31, 2013Idenix Pharmaceuticals Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -25.28M |
| Dec. 31, 2012 | -21.35M |
| Sept. 30, 2012 | -17.52M |
| June 30, 2012 | -26.19M |
| March 31, 2012 | -17.63M |
| Dec. 31, 2011 | -13.00M |
| Sept. 30, 2011 | -13.92M |
| June 30, 2011 | -13.44M |
| March 31, 2011 | -15.00M |
| Dec. 31, 2010 | |
| Sept. 30, 2010 | -14.20M |
| June 30, 2010 | -8.999M |
| March 31, 2010 | -14.40M |
| Dec. 31, 2009 | -13.17M |
| Sept. 30, 2009 | -11.89M |
| June 30, 2009 | -12.87M |
| March 31, 2009 | 1.297M |
| Dec. 31, 2008 | -13.36M |
| Sept. 30, 2008 | -20.19M |
| June 30, 2008 | -17.99M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
IDIX Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Achillion Pharmaceuticals | -13.31M |
| Vertex Pharmaceuticals | -82.38M |
| Peregrine Pharmaceuticals | -6.929M |
IDIX Free Cash Flow Rankings
| Overall |
51st percentile 3894 of 8006 |
| Sector |
25th percentile 510 of 686 in Healthcare |
| Industry |
33rd percentile 166 of 248 in Biotechnology |
IDIX Free Cash Flow Range, Past 5 Years
| Minimum | -26.19M | Jun 2012 |
| Maximum | 1.297M | Mar 2009 |
| Average | -15.22M |
